Combination of mTOR inhibition and paclitaxel as a personalised strategy in the context of MYC-amplified high-grade serous ovarian cancer
暂无分享,去创建一个
M. Jimenez-Linan | J. Brenton | A. Piskorz | D. Couturier | M. Vias | R. Crawford | F. C. Martins | K. Hosking | D. Sanders | J. Hall | I. Santiago